Login to get immediate access to this content.
LoginSpeaker: Hope S Rugo, USA
Abstract discussed:
- 183MO - Capivasertib and fulvestrant for AI-resistant HR+/HER2– ABC: Watch the session from ESMO Breast 2024 now
The speakers and studies featured in this video series were selected independently by ESMO.
Published July 2024